Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-08-2006 | Clinical Investigation

Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma

Authors: Yoko Inagaki, Yukihiko Mashima, Tomoyo Funayama, Yuichiro Ohtake, Nobuo Fuse, Noriko Yasuda, Takeo Fukuchi, Akira Murakami, Yoshihiro Hotta

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2006

Abstract

Background

The purpose of this study was to determine whether genetic polymorphisms affecting high-density lipoprotein (HDL)-associated antioxidant enzymes were associated with open-angle glaucoma (OAG). The rationale for this study was that the modification of low-density lipoprotein (LDL) by HDL prevents oxidative modification which can then cause dysfunction of endothelial cells.

Methods

We studied 284 normal Japanese controls and 555 Japanese patients with OAG, including primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG). The possible associations of polymorphisms of PON1/L55M, PON1/Q192R, PON2/S311C, and PAF-AH/V279F with OAG were investigated. We compared the genotype distributions and allele frequency in controls and patient groups. The age at diagnosis, intraocular pressure (IOP) at diagnosis, and visual field score at diagnosis were examined for association with polymorphisms.

Results

The distributions of genotypes and allele frequency for the four polymorphisms were not significantly different between any patient group and controls. In NTG patients, 55M carriers of the PON1 gene were significantly older at diagnosis than 55M non-carriers (P=0.001). The IOP at diagnosis was significantly higher in glaucoma patients carrying 192R in the PON1 gene than in patients not carrying 192R (P=0.006). No significant differences were seen in clinical characteristics of OAG patients in relation to other polymorphisms.

Conclusion

PON1 gene polymorphisms may influence the features of Japanese patients with OAG.

Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du B (1998) Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 18:1617–1624PubMed

Brezin AP, Bechetoille A, Hamard P, Valtot F, Berkani M, Belmouden A, Adam MF, Dupont de Dinechin S, Bach JF, Garchon HJ (1997) Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy. J Med Genet 34:546–552PubMedCrossRef

Cao H, Girard-Globa A, Berthezene F, Moulin P(1999) Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q–>R genetic polymorphism. J Lipid Res 40:133–139PubMed

Chang IL, Elner G, Yue YJ, Cornicelli A, Kawa JE, Elner VM (1991) Expression of modified low-density lipoprotein receptors by trabecular meshwork cells. Curr Eye Res 10:1101–1112PubMedCrossRef

Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ (2002) Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 70:1575–1581CrossRefPubMed

Deakin S, Leviev I, Guernier S, James RW (2003) Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 23:2083–2089CrossRefPubMed

Dielemans I, Vingerling JR, Wolfs RC, Hohman A, Grobbee DE, de Jong PT (1994) The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam study. Ophthalmology 101:1851–1855PubMed

Flammer J, Haefliger IO, Orgul S, Resink T(1999)Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 8:212–219PubMedCrossRef

Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, Amoako-Mensah T, Eichler HG, Vass C, Schmetterer L (2004) Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 45:834–839CrossRefPubMed

10.

Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, Kimura I, Suzuki K, Ideta H, Nakamoto K, Yasuda N, Fujimaki T, Murakami A, Asaoka R, Hotta Y, Tanihara H, Kanamoto T, Mishima H, Fukuchi T, Abe H, Iwata T, Shimada N, Kudoh J, Shimizu N, Mashima Y(2004) Variants in optineurin gene and their association with tumor necrosis factor-α polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 45:4359–4367CrossRefPubMed

11.

Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62–66PubMedCrossRef

12.

Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group (2002) Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268–1279PubMed

13.

Henry E, Newby DE, Webb DJ, O’Brien C (1999) Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 40:1710–1714PubMed

14.

Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435–442CrossRefPubMed

15.

Ishikawa K, Funayama T, Ohtake Y, Tanino T, Kurosaka D, Suzuki K, Ideta H, Fujimaki T, Tanihara H, Asaoka R, Naoi N, Yasuda N, Iwata T, Mashima Y (2004) Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography. J Glaucoma 13:466–471CrossRefPubMed

16.

Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H (2002) Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 110:89–94CrossRefPubMed

17.

Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima H, Shimizu H, Tomita G, Inoue Y, Kitazawa Y, Tajimi Study Group, Japan Glaucoma Society. (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111:1641–1648CrossRefPubMed

18.

Kakafika AI, Xenofontos S, Tsimihodimos V, Tambaki AP, Lourida ES, Kalaitzidis R, Cariolou MA, Elisaf M, Tselepis AD (2003) The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity. J Lipid Res 44:1919–1926CrossRefPubMed

19.

Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ (1992) Prevalence of glaucoma. The Beaver Dam eye study. Ophthalmology 99:1499–1504PubMed

20.

Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, Arco DA, Neri BP, Brow MA (1999) Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 17:292–296CrossRefPubMed

21.

Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57–60CrossRefPubMed

22.

Mackness MI, Arrol S, Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152–154CrossRefPubMed

23.

Mackness MI, Arrol S, Abbott C, Durrington PN (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104:129–135CrossRefPubMed

24.

Mackness MI, Durrington PN, Mackness B (2000) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383–388CrossRefPubMed

25.

Martinelli N, Girelli D, Olivieri O, Stranieri C, Trabetti E, Pizzolo F, Friso S, Tenuti I, Cheng S, Grow MA, Pingnatti PF, Corrocher R (2004) Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Invest 34:14–20CrossRefPubMed

26.

McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004) Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122:822–826CrossRefPubMed

27.

Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM (2004) PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Cardiol 94:73–77CrossRefPubMed

28.

Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498–507CrossRefPubMed

29.

Ruiz J, Blanche H, James RW, Garin MC,Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P (1995) Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869–872CrossRefPubMed

30.

Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75–79PubMedCrossRef

31.

Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1994) Family history and risk of primary open angle glaucoma. The Baltimore eye survey. Arch Ophthalmol 112:69–73PubMed

32.

Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A,Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K (2003) Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit 9:CR260–264

33.

Watson AD, Navab M, Hama SY, Sevanian A (1995) Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95:774–782PubMedCrossRef

34.

Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J (2004) Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363:689–695CrossRefPubMed

35.

Wilson MR (1996) Epidemiology of chronic open-angle glaucoma. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas, vol II: Clinical science. Mosby ,St. Louis, pp753–768

36.

Yablonski ME (1979) An analysis of the "vascular hypothesis" concerning optic disc pathology in glaucoma. Ann Ophthalmol 11:67–69PubMed

37.

Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M (2001) Association of a G994->T (Val279->Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy. J Hum Genet 46:436–441CrossRefPubMed

38.

Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson’s disease: a meta-analysis. J Hum Genet 49:474–481CrossRefPubMed

Title: Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma
Authors: Yoko Inagaki
Yukihiko Mashima
Tomoyo Funayama
Yuichiro Ohtake
Nobuo Fuse
Noriko Yasuda
Takeo Fukuchi
Akira Murakami
Yoshihiro Hotta
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2006
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-005-0200-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2006

Neuroprotective effect of latanoprost on rat retinal ganglion cells

Choroidal dye filling velocity in patients with Vogt–Koyanagi–Harada disease

Allergic reaction to hyaluronidase: a rare cause of orbital inflammation after cataract surgery

Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1

An objective technique to measure the depth-of-focus in free space

Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery